P
Peter M. Irving
Researcher at King's College London
Publications - 369
Citations - 11347
Peter M. Irving is an academic researcher from King's College London. The author has contributed to research in topics: Medicine & Ulcerative colitis. The author has an hindex of 51, co-authored 305 publications receiving 8313 citations. Previous affiliations of Peter M. Irving include University of Cambridge & Southend University Hospital NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Gluten Causes Gastrointestinal Symptoms in Subjects Without Celiac Disease: A Double-Blind Randomized Placebo-Controlled Trial
Jessica R Biesiekierski,Evan Newnham,Peter M. Irving,Jacqueline Susanne Barrett,Melissa Haines,James D. Doecke,Susan Joy Shepherd,Jane G. Muir,Peter R. Gibson +8 more
TL;DR: “Non-celiac gluten intolerance” may exist, but no clues to the mechanism were elucidated and there were no differences in any end point in individuals with or without DQ2/DQ8.
Journal ArticleDOI
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome
Derrick K Ong,Shaylyn B Mitchell,Shaylyn B Mitchell,Jacqueline Susanne Barrett,Susan Joy Shepherd,Peter M. Irving,Jessica R Biesiekierski,Stuart C. Smith,Peter R. Gibson,Jane G. Muir +9 more
TL;DR: Reduction of short‐chain poorly absorbed carbohydrates (FODMAPs) in the diet reduces symptoms of irritable bowel syndrome, and symptoms produced in response to diets that differed only in FODMAP content are compared.
Journal ArticleDOI
Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome
Heidi M Staudacher,Miranda Lomer,Miranda Lomer,Jacqueline L Anderson,Jacqueline Susanne Barrett,Jane G. Muir,Peter M. Irving,Peter M. Irving,Kevin Whelan +8 more
TL;DR: In this paper, a randomized controlled trial aimed to investigate the effects of fermentable carbohydrate restriction on luminal microbiota, SCFA, and GI symptoms in patients with irritable bowel syndrome (IBS).
Journal ArticleDOI
Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome
TL;DR: A low FODMAP diet appears to be more effective than standard dietary advice for symptom control in IBS.
Journal ArticleDOI
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Nicholas A. Kennedy,Nicholas A. Kennedy,Nicholas A. Kennedy,Graham A. Heap,Harry D Green,Benjamin Hamilton,Claire Bewshea,Gareth J. Walker,Amanda Thomas,Rachel Nice,Mandy H Perry,Sonia Bouri,Neil Chanchlani,Neel Heerasing,Peter Hendy,Simeng Lin,Daniel R. Gaya,J R Fraser Cummings,J R Fraser Cummings,Christian P. Selinger,Charlie W. Lees,Charlie W. Lees,Ailsa L. Hart,Miles Parkes,Shaji Sebastian,John C Mansfield,Peter M. Irving,James O. Lindsay,Richard K Russell,Timothy J. McDonald,Dermot P.B. McGovern,James R Goodhand,James R Goodhand,Tariq Ahmad,Tariq Ahmad,Vinod B. Patel,Zia Mazhar,Rebecca Saich,Ben Colleypriest,Tony C.K. Tham,Tariq Iqbal,Vishal Kaushik,Senthil V. Murugesan,Salil Singh,Sean Weaver,Cathryn Preston,Assad Butt,Melissa A. Smith,Dharamveer Basude,Amanda Beale,Sarah Langlands,Natalie C. Direkze,Franco Torrente,Juan De La Revella Negro,Christopher Macdonald,Stephen M. Evans,Anton V J Gunasekera,Alka Thakur,David A Elphick,Achuth Shenoy,Chuka U. Nwokolo,Anjan Dhar,Andrew T. Cole,Anurag Agrawal,Stephen Bridger,Julie Doherty,Sheldon C. Cooper,Shanika de Silva,Craig Mowat,Phillip Mayhead,Charlie W. Lees,Gareth R. Jones,James W Hart,Lisa Gervais,Paul Dunckley,Tariq Mahmood,Paul R. Banim,Sunil Sonwalkar,Deb Ghosh,Rosemary H Phillips,Amer Azaz,Richard Shenderey,Lawrence Armstrong,Claire Bell,Radhakrishnan Hariraj,Helen Matthews,Hasnain Jafferbhoy,Veena Zamvar,John de Caestecker,Anne Willmott,Richard A. Miller,Palani Sathish Babu,Christos Tzivinikos,Stuart Bloom,Guy Chung-Faye,Nicholas M. Croft,John Fell,Marcus Harbord,Ailsa Hart,Ben Hope,James O Lindsay,Joel Mawdsley,Alistair McNair,Kevin J. Monahan,Charles Murray,Timothy R. Orchard,Thankam Paul,Richard Pollok,Neil Shah,Matthew W. Johnson,Anita Modi,Kasamu Dawa Kabiru,B K Baburajan,Bim Bhaduri,Andrew A. Fagbemi,Scott Levison,Jimmy K. Limdi,Gill Watts,Stephen Foley,Arvind Ramadas,George MacFaul,John C. Mansfield,Leonie Grellier,Mary-Anne Morris,Mark Tremelling,Christopher J. Hawkey,Sian Kirkham,Charles Pj Charlton,Astor Rodrigues,Alison Simmons,Stephen Lewis,Jonathon Snook,Mark Tighe,Patrick Goggin,Aminda De Silva,Simon Lal,Mark S. Smith,Simon Panter,Suranga Dharmisari,M J Carter,David Watts,Zahid Mahmood,Bruce McLain,Sandip Sen,Anna J Pigott,David Hobday,Emma Wesley,R B Johnston,Cathryn Edwards,John Beckly,Deven Vani,Subramaniam Ramakrishnan,Rakesh Chaudhary,Nigel Trudgill,Rachel Cooney,Andrew Bell,Neeraj Prasad,John N. Gordon,Matthew J Brookes,Andy Li,Stephen Gore +160 more
TL;DR: Clinical and pharmacokinetic factors that predict primary non-response at week 14 after starting treatment, non-remission at week 54, and adverse events leading to drug withdrawal are identified.